Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

Clinical trial NCT06959108 · RECRUITING

Trial details

NCT number: NCT06959108
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Head and Neck Squamous Cell Carcinoma

Start date: 2025-10-13
Primary completion: 2029-06-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.